Abbott Laboratories (Pakistan) Limited (PSX:ABOT)
1,074.03
-25.36 (-2.31%)
At close: Nov 11, 2025
PSX:ABOT Revenue
Abbott Laboratories (Pakistan) had revenue of 19.82B PKR in the quarter ending September 30, 2025, with 14.14% growth. This brings the company's revenue in the last twelve months to 74.84B, up 17.28% year-over-year. In the year 2024, Abbott Laboratories (Pakistan) had annual revenue of 68.18B with 22.90% growth.
Revenue (ttm)
74.84B
Revenue Growth
+17.28%
P/S Ratio
1.40
Revenue / Employee
53.23M
Employees
1,406
Market Cap
105.15B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 68.18B | 12.70B | 22.90% |
| Dec 31, 2023 | 55.48B | 6.22B | 12.62% |
| Dec 31, 2022 | 49.26B | 6.69B | 15.71% |
| Dec 31, 2021 | 42.57B | 7.29B | 20.65% |
| Dec 31, 2020 | 35.28B | 5.13B | 17.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| GlaxoSmithKline Pakistan | 62.07B |
| The Searle Company | 30.67B |
| Shifa International Hospitals | 28.52B |
| AGP Limited | 27.73B |
| Highnoon Laboratories | 26.61B |
| Ferozsons Laboratories | 20.27B |
| Citi Pharma | 13.30B |
| Macter International | 10.96B |